GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » King International Investment Ltd (HKSE:00928) » Definitions » Market Cap

King International Investment (HKSE:00928) Market Cap : HK$144.3 Mil (As of May. 11, 2024)


View and export this data going back to 2002. Start your Free Trial

What is King International Investment Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). King International Investment's share price for the quarter that ended in Sep. 2023 was HK$0.074. King International Investment's Shares Outstanding (EOP) for the quarter that ended in Sep. 2023 was 1,542.0 Mil. Therefore, King International Investment's market cap for the quarter that ended in Sep. 2023 was HK$114.1 Mil.

King International Investment's quarterly market cap declined from Sep. 2022 (HK$172.7 Mil) to Mar. 2023 (HK$146.5 Mil) and declined from Mar. 2023 (HK$146.5 Mil) to Sep. 2023 (HK$114.1 Mil).

King International Investment's annual market cap declined from Mar. 2021 (HK$282.7 Mil) to Mar. 2022 (HK$155.5 Mil) and declined from Mar. 2022 (HK$155.5 Mil) to Mar. 2023 (HK$146.5 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. King International Investment's Enterprise Value for Today is HK$149.9 Mil.


King International Investment Market Cap Historical Data

The historical data trend for King International Investment's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

King International Investment Market Cap Chart

King International Investment Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 299.84 160.63 282.71 155.49 146.49

King International Investment Semi-Annual Data
Mar14 Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 213.31 155.49 172.71 146.49 114.11

Competitive Comparison of King International Investment's Market Cap

For the Diagnostics & Research subindustry, King International Investment's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


King International Investment's Market Cap Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, King International Investment's Market Cap distribution charts can be found below:

* The bar in red indicates where King International Investment's Market Cap falls into.



King International Investment Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

King International Investment's Market Cap for the fiscal year that ended in Mar. 2023 is calculated as

Market Cap (A: Mar. 2023 )=Share Price (A: Mar. 2023 )*Shares Outstanding (EOP) (A: Mar. 2023 )
=HK$0.095*1542.03
=HK$146.5

King International Investment's Market Cap for the quarter that ended in Sep. 2023 is calculated as

Market Cap (Q: Sep. 2023 )=Share Price (Q: Sep. 2023 )*Shares Outstanding (EOP) (Q: Sep. 2023 )
=HK$0.074*1542.03
=HK$114.1

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


King International Investment  (HKSE:00928) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


King International Investment Market Cap Related Terms

Thank you for viewing the detailed overview of King International Investment's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


King International Investment (HKSE:00928) Business Description

Traded in Other Exchanges
N/A
Address
18 Harbour Road, Room 6307-08, 63rd Floor, Central Plaza, Wanchai, Hong Kong, HKG
King International Investment Ltd formerly Life Healthcare Group Ltd is an investment holding company. The company's operating segment includes the Healthcare products and services business and Money lending business. It generates maximum revenue from the Healthcare products and services business segment. Geographically, it derives a majority of revenue from PRC. The group is primarily a provider of genetic testing and health data analysis services.

King International Investment (HKSE:00928) Headlines

No Headlines